Free Robotic mastectomy surgeon sues Monmouth, alleging defamation, antitrust violations November 22, 2019Vol.45 No.44By Paul Goldberg
Hahn pledges to be guided by “science and data” in considering vape flavor ban if confirmed at FDA November 22, 2019Vol.45 No.44By Alexandria Carolan
Conversation with The Cancer LetterFreeReal-world Evidence Learning to harmonize: Ten health care research organizations tell us how they formulated common definitions for real-world endpoints November 22, 2019Vol.45 No.44By Matthew Bin Han Ong
Conversation with The Cancer LetterFreeReal-world Evidence Friends’ Allen: Real-world endpoints can be used to fill evidence gaps about performance of medical products November 22, 2019Vol.45 No.44By Matthew Bin Han Ong
FreeReal-world Evidence Real-world evidence at a glance: How a collaboration of “frenemies” produced common definitions for real-world endpoints November 22, 2019Vol.45 No.44By Matthew Bin Han Ong
FreeTrials & Tribulations Noorchashm: “Biopsy your tumors”—with failed fibroid guidelines, gynecologists might as well be reading tea leaves November 15, 2019Vol.45 No.43By Hooman Noorchashm
White papers by Friends address external controls, progression on immunotherapy, companion diagnostics November 15, 2019Vol.45 No.43By Matthew Bin Han Ong
Conversation with The Cancer Letter Teitell: How immunotherapy became the fourth pillar of cancer care at UCLA November 15, 2019Vol.45 No.43By Paul Goldberg
Conversation with The Cancer LetterFree U.S. Nobel laureates tell us what they think about cancer research, moonshots, the dark side, funding, meritocracy, herd mentality, Trump, and joy November 15, 2019Vol.45 No.43By Alexandria Carolan
FreeTrials & Tribulations Major gaps persist in Americans’ knowledge of and actions on cancer prevention November 08, 2019Vol.45 No.42By Howard A. "Skip" Burris III
